The present study was undertaken to evaluate whether the site of ovulation affects the following follicular phase length and pre-embryo development during infertility treatment with ovarian stimulation using clomiphene citrate. A total of 363 cycles in 97 patients undergoing infertility treatment (182 intrauterine insemination (IUI) cycles in 60 patients and 181 in-vitro fertilization (IVF) cycles in 52 patients) were studied. The cycles were divided into two main groups: preceding unilateral ovulation (PUO) and preceding bilateral ovulation (PBO). In the PUO group, the cycles were subdivided into contralateral ovulation, bilateral ovulation and ipsilateral ovulation. In IVF cycles alone, bilateral ovulations were further divided into bilateral ovulation-contralateral side and bilateral ovulation, ipsilateral side. Contralateral ovulations were seen in 134 of 240 cycles (56%), excluding bilateral ovulation and PBO. The follicular phase length in contralateral ovulation (16.2 ⍨ 2.6 days, mean Ϯ SD) was significantly (P < 0.05) shorter than that of ipsilateral ovulation (16.9 ⍨ 2.8). There were no significant differences of follicular phase length among contralateral ovulation, bilateral ovulation and PBO. Of IVF cycles including contralateral ovulation-ipsilateral ovulation and bilateral ovulation a total of 107 preovulatory follicles was assessed in the contralateral side (contralateral ovulation ⍣ bilateral ovulation-contralateral side) and 97 in the ipsilateral side (ipsilateral ovulation ⍣ bilateral ovulation, ipsilateral side). The oocyte retrieval rate (88%), fertilization rate (84%), cleavage rate (95%), embryo transfer rate (70%) of contralateral follicles were higher than those of ipsilateral follicles (71, 62, 86, 38% respectively) and those of PBO (76, 62, 87, 41% respectively). The total pregnancy rate of both IUI and IVF did not differ among contralateral ovulation (15%), ipsilateral ovulation (8%), bilateral ovulation (11%) and PBO (10%). The results confirm and extend our previous findings in natural cycles, suggesting that local ovarian factors, e.g. from corpus luteum, affect the health of preovulatory follicle and the enclosed oocyte in the same ovary (ipsilateral) negatively. Contralateral selection of preovulatory follicles in the succeeding cycle shortens the follicular phase length and favours pre-embryo 1590 © European Society for Human Reproduction and Embryology development. The chance of conceiving during ovarian stimulation with clomiphene citrate may thus be affected by the site of ovulation in the previous cycle.
Introduction
The duration of the follicular phase of the natural menstrual cycle is shorter when ovulations alternate between the two ovaries (i.e. contralateral) compared to when ovulations occur from the same ovary (i.e. ipsilateral) (Wallach et al., 1973; Potashnik et al., 1987; Fukuda et al., 1996) . Moreover, when the dominant follicle develops in the contralateral ovary, the follicular fluid contains a more favourable androgen to oestrogen ratio and the oocyte is more prone to undergo fertilization and pre-embryo development in vitro (Fukuda et al., 1996) . From this study, it was suggested that the corpus luteum secreted local ovarian factors which negatively affected follicular health of the responsive cohort of follicles of the next menstrual cycle, confirming earlier works [Goodman et al., 1977 (rhesus monkey) ; Tyndale-Biscoe and Hawkins, 1977 (marsupial) ; diZerega and Hodgen, 1981 (rhesus monkey); Renfree et al., 1982 (marsupial) ; Fukuda et al., 1983 (rat) ; Tsuji et al., 1983 (human) ]. In the preceding luteal phase, the diameter of the largest follicle in the ipsilateral ovary with corpus luteum was smaller than that of the contralateral ovary without corpus luteum, suggesting a local negative effect of the corpus luteum already at this stage (Fukuda et al., 1997) . A strong candidate for a local ovarian factor negatively affecting follicular growth may be progesterone, which is secreted in high concentrations by the corpus luteum during the luteal phase. It has been suggested that progesterone or corpus luteum exert their local antifolliculogenic effect before the beginning of the gonadotrophin-dependent follicular growth [Fukuda et al., 1980 [Fukuda et al., (rat), 1983 [Fukuda et al., (rat), 1997 ].
The present study was undertaken to evaluate whether the site of ovulation and corpus luteum affects the succeeding follicular phase length and pre-embryo development in cycles in which clomiphene citrate (CC) is used for ovarian stimulation.
Materials and methods
This study was performed between June 1990 and May 1997, and includes a total of 97 patients (age 28.7 Ϯ 5.6 years, mean Ϯ SD, range 22-41) undergoing 363 cycles for treatment of infertility. Sixty patients underwent 182 intrauterine insemination (IUI) cycles and 52 Figure 1 . Classification of clomiphene citrate cycles. PUO, preceding unilateral ovulation; PBO, preceding bilateral ovulation; CO, contralateral ovulation; BO, bilateral ovulation; IO, ipsilateral ovulation; BOC, bilateral ovulation-contralateral side; BOI, bilateral ovulation-ipsilateral side; UO, unilateral ovulation. Underlined parts show the four major groups.
patients underwent 181 in-vitro fertilization (IVF) cycles; 15 patients underwent both IUI and IVF cycles. None of the patients received exogenous gonadotrophins for ovarian stimulation, but all received 50-150 mg/day of CC (Serophene; Serono, Tokyo, Japan) from day 5 of the cycle for 5 days. The minimum dose of 50 mg/day for 5 days was usually given as a mild ovarian stimulation. The indications for ovarian stimulation were as follows: (i) patients with an ovulation disorder, i.e. oligo-ovulation, anovulatory cycle; (ii) patients showing an endogenous LH surge with a dominant follicle of Ͻ17 mm in diameter during a natural IVF cycle. Follicular development was monitored by transvaginal ultrasound (SSA-250A Toshiba scanner with a 5.0 MHz convex vaginal probe or Sonovista CS or EX Mochida scanner with a 5.0, 6.0 or 7.5 MHz mechanical sector vaginal probe). The mean number of cycles examined in each patient was 3.5 (range: 1-9). Ovulation was predicted by the urinary luteinizing hormone surge (L-check: Nipro, Osaka or Gold Sign LH: Morinaga, Tokyo, Japan). None of the patients showed an ovarian cyst, i.e. persistent follicular cyst, chocolate cyst, nor had they experienced ovarian surgery.
Side of ovulation and follicular phase length
Each follicle reaching a diameter of 14 mm was followed daily until ovulation or oocyte retrieval. During the luteal phase (i.e. from ϩ5 day after ovulation onwards) the site(s) of corpora lutea was confirmed. When one or more preovulatory follicle(s) and corpora lutea appeared in only one ovary in the preceding cycle, this cycle was defined as preceding unilateral ovulation (PUO). If preovulatory follicles appeared in both ovaries in the preceding cycle, the cycle was defined as preceding bilateral ovulation (PBO). The preceding cycle (PUO or PBO) was a natural cycle or a CC cycle. Anovulatory cycles and cycles with follicular phase length of Ͼ26 days were excluded from this study.
If pre-ovulatory follicles were observed only in one ovary in a cycle immediately following a PUO cycle, this cycle was defined as either contralateral ovulation or ipsilateral ovulation, respectively. When preovulatory follicles developed in both ovaries in a cycle immediately following a PUO cycle, this was classified as a bilateral ovulation.
Irrespective of unilateral ovulation or bilateral ovulation in the treatment cycle, cycles which succeeded a PBO cycle were classified as preceding bilateral ovulation (PBO), as shown in Figure 1 .
Defining cycle day 1 as the first day of menstruation, the day of follicular rupture or oocyte retrieval was used to monitor the follicular phase length (i.e. if follicle rupture occurred on day 14, follicular phase length is 14 days). 
IVF procedure
Of 181 IVF cycles in 52 couples, 57 cycles showed contralateral ovulation (these ovulations were PUO), 50 ipsilateral ovulation and 28 bilateral ovulation, while 46 cycles were PBO. Causes of infertility were as follows: male factor, 45 couples; unknown, 7 couples. In at least one IVF attempt, all these couples showed pre-embryo development. All procedures were performed as follows. In brief, human chorionic gonadotrophin (HCG) was given when the leading follicle measured Ͼ20 mm in diameter and the oocyte was retrieved 34-35 h after HCG injection using transvaginal ultrasound guided follicle puncture. Preovulatory follicles measuring ജ14 mm were aspirated and flushed up to 6 times. Rates of oocyte retrieval, fertilization, cleavage, embryo transfer were assessed in contralateral ovulation, ipsilateral ovulation, bilateral ovulation and PBO and expressed per total number of follicles, and not per cycle. Bilateral ovulation was subdivided into two groups: bilateral ovulation-contralateral side and bilateral ovulation-ipsilateral side as shown in Figure 1 . In cases of bilateral ovulation, the retrieved oocytes were cultured separately, allowing for an individual assessment of each side. Statistical evaluation of follicular phase length was performed using unpaired Student's t-test and that of IVF and pregnancy outcome using χ 2 , Fisher's exact test. Differences were considered significant at P Ͻ 0.05. Results are presented as mean Ϯ SD.
Results

Side of ovulation and follicular phase length
Contralateral ovulation occurred in 134 of 240 cycles (56%), excluding bilateral ovulation and PBO. The follicular phase length in contralateral ovulation (16.2 Ϯ 2.6 days, mean Ϯ SD) was significantly (P Ͻ 0.05) shorter than that of ipsilateral ovulation (16.9 Ϯ 2.8). There were no significant differences of follicular phase length among contralateral ovulation, bilateral ovulation and PBO as shown in Table I .
IVF outcome and pregnancy outcome
The oocyte retrieval rate/follicle, the fertilization rate/follicle, the cleavage rate/follicle and the embryo transfer rate/ follicle in contralateral ovulation, ipsilateral ovulation and bilateral ovulation are shown in Table II . IVF outcomes of total contralateral follicles (including contralateral ovulation and bilateral ovulation-contralateral side), total ipsilateral follicles (including ipsilateral ovulation and bilateral ovulationipsilateral side), and also PBO are shown in Table III . The oocyte retrieval rate in contralateral follicles (94/107: 88%) was significantly higher than that of ipsilateral follicles (69/97: 71%) (P Ͻ 0.005). In addition, the fertilization rate (79/94: 84%) and cleavage rate (75/79: 95%) in contralateral follicles were also higher than those of ipsilateral follicles (43/69: 60% and 37/43: 86% respectively). As a result, the embryo transfer rate per follicle in contralateral follicles (75/ 107 ϭ 70%) was significantly higher than that of ipsilateral follicles (37/97: 38%) (P Ͻ 0.001). These rates of contralateral follicles were also higher than those of PBO as shown in Table III . The total pregnancy rate per cycle of both IUI and IVF in contralateral ovulation (20/134: 15%) was not significantly different from that of ipsilateral ovulation (9/106: 8%), of bilateral ovulation (6/54: 11%) or that of PBO (7/69: 10%), as shown in Table IV .
Discussion
The present study demonstrates that the follicular phase length is significantly shorter when ovulations alternate between the two ovaries, compared to when ovulations occur in the same ovary in successive cycles during ovarian stimulation with CC. Furthermore, the oocytes of the preovulatory follicles are more prone to undergo fertilization and pre-embryo development when the preovulatory follicles develop in the ovary 1592 opposite to where ovulation took place in the preceding cycle compared to when the follicle develops in the same ovary. Therefore, the present study extends the observations from natural menstrual cycles (Fukuda et al., 1996) , showing that intra-ovarian factors affect follicular growth, oocyte quality, fertilization and pre-embryo development even during ovarian stimulation.
It has been reported that contralateral ovulation occurred in 44 out of 99 CC cycles (44%), excluding bilateral ovulation cycles (Check et al., 1992) . This is in contrast to the present study in which contralateral ovulation occurred at a rate of 56% excluding bilateral ovulation cycles. This difference is not readily explained, but the rate we have observed compares favourably to that (57%) of our previous study during natural menstrual cycles (Fukuda et al., 1996) .
Though the follicular phase length of contralateral ovulation (134 cycles) is significantly shorter than that of ipsilateral ovulation (106 cycles), it is not significantly different from those of bilateral ovulation (54 cycles) and PBO (69 cycles). This similarity may be due to the small numbers of bilateral ovulation and PBO. Further data are needed to verify this.
PBO always shows pre-ovulatory follicle development in the same ovary, similar to ipsilateral ovulation. Therefore PBO indicates a poor IVF outcome (embryo transfer rate of 41%) quite similar to that of ipsilateral follicles (38%). The PBO result is in agreement with an earlier study showing poor ovulation responses in women with single ovaries (Lass et al., 1997) .
It is well established that healthy follicles show lower androgen concentrations and a higher oestrogen:androgen ratio than atretic follicles (McNatty et al., 1979; Westergaard et al., 1986; Yding Andersen, 1993 Fukuda et al., 1995) . We have previously shown that follicular fluids from dominant follicles in contralateral ovulation cycles show a more favourable oestrogen:androgen ratio than those from dominant follicles in ipsilateral ovulation cycles, suggesting that contralateral dominant follicles are healthier than ipsilateral dominant follicles (Fukuda et al., 1996) . The present results indicating shorter follicular phase length and more favourable pre-embryo development in contralateral ovulation during CC cycles are quite similar to those obtained from natural cycles. Therefore, it is likely that during CC stimulation also contralateral, preovulatory follicles are healthier than ipsilateral ones. The present study using CC for ovarian stimulation and our previous study in natural cycles suggest an antifolliculogenic effect of the corpus luteum. A negative effect of the corpus luteum on follicular growth was previously observed in the luteal phase, since the diameter of the largest follicle in the ipsilateral ovary with corpus luteum was smaller than that of the contralateral ovary without corpus luteum (Fukuda et al., 1997) .
Which local ovarian factors from the corpus luteum may have a negative effect upon neighbouring follicles? A strong candidate may be progesterone, which is secreted in high concentrations by the corpus luteum during the luteal phase. Progesterone has been shown to have an antifolliculogenic effect (Akahori, 1978; Fukuda et al., 1980; Schreiber et al., 1980 Schreiber et al., , 1981 Schreiber et al., , 1982 Tyler et al., 1980) , and it has been suggested that progesterone or corpus luteum exerts its local antifolliculogenic effect before the beginning of the gonadotrophin-dependent follicular growth (Fukuda et al., 1980 (Fukuda et al., , 1983 (Fukuda et al., , 1997 . Another candidate may be inhibin, which has been shown to increase the follicular androgen production synergistically with LH and may contribute to unfavourable conditions for follicular health .
So far, we have mainly discussed local ovarian factors from the corpus luteum. However, there are some reports concerning the influence of the dominant follicle on the neighbouring subordinate follicles and/or oocytes during the late follicular phase (diZerega et al., 1982; Pache et al., 1990; Smith et al., 1996; Spears et al., 1996; Guet et al., 1997) . Another local factor may be due to the inflammatory action of ovulation (Farookhi 1981; Espey 1994) or mechanical effect of ovulation (Murdoch 1994) . It would thus be interesting to study the effect of the dominant follicle or ovulation itself on the responsive cohort of the neighbouring small follicles for the succeeding menstrual cycle.
In conclusion, the present results from CC stimulated cycles confirm our previous findings in natural cycles, suggesting that local ovarian factors, possibly from the corpus luteum, affect the health of preovulatory follicle and the enclosed oocyte negatively. Progesterone and/or inhibin secreted by the corpus luteum may locally affect neighbouring follicular growth negatively, already in the preceding luteal phase. Therefore contralateral selection of the preovulatory follicle in the succeeding cycle shortens the follicular phase length and may cause development of a healthier oocyte favouring pre-embryo development. The chance of conceiving during the CC cycle may be affected by the relationship between the site of ovulation in the preceding cycle and the site of the preovulatory follicle in the succeeding cycle. Further detailed study is obviously needed to determine the local ovarian factors from the corpus luteum and/or the preovulatory follicle, considering not only the final 14 day gonadotrophin-dependent follicular growth but early follicular growth prior to the final menstrual cycle as well.
